Department of Molecular and Cell Biology, Henry Wellcome Building, University of Leicester, Leicester, United Kingdom.
Institute of Cardiovascular Sciences, Institute of Biomedical Research Building, University of Birmingham, Birmingham, United Kingdom.
Thromb Haemost. 2018 Feb;118(2):369-380. doi: 10.1160/TH17-07-0530. Epub 2018 Jan 29.
Platelets express key receptors of the innate immune system such as FcγRIIa and Toll-like receptors (TLR). P2X1 cation channels amplify the platelet responses to several major platelet stimuli, particularly glycoprotein (GP)VI and TLR2/1, whereas their contribution to Src tyrosine kinase-dependent FcγRIIa receptors remains unknown. We investigated the role of P2X1 receptors during activation of FcγRIIa in human platelets, following stimulation by cross-linking of an anti-FcγRIIa monoclonal antibody (mAb) IV.3, or bacterial stimulation with . Activation was assessed in washed platelet suspensions via measurement of intracellular Ca ([Ca]) increases, ATP release and aggregation. P2X1 activity was abolished by pre-addition of α,β-meATP, exclusion of apyrase or the antagonist NF449. FcγRIIa activation evoked a robust increase in [Ca] (441 ± 33 nM at 30 μg/mL mAb), which was reduced to a similar extent (to 66-70% of control) by NF449, pre-exposure to α,β-meATP or apyrase omission, demonstrating a significant P2X1 receptor contribution. FcγRIIa activation-dependent P2X1 responses were partially resistant to nitric oxide (NO), but abrogated by 500 nM prostacyclin (PGI). Aggregation responses to bacteria and FcγRIIa activation were also inhibited by P2X1 receptor desensitization (to 66 and 42% of control, respectively). However, FcγRIIa-mediated tyrosine phosphorylation and ATP release were not significantly altered by the loss of P2X1 activity. In conclusion, we show that P2X1 receptors enhance platelet FcγRIIa receptor-evoked aggregation through an increase in [Ca] downstream of the initial tyrosine phosphorylation events and early dense granule release. This represents a further route whereby ATP-gated cation channels can contribute to platelet-dependent immune responses in vivo.
血小板表达先天免疫系统的关键受体,如 FcγRIIa 和 Toll 样受体 (TLR)。P2X1 阳离子通道放大了血小板对几种主要血小板刺激物的反应,特别是糖蛋白 (GP)VI 和 TLR2/1,而它们对 Src 酪氨酸激酶依赖性 FcγRIIa 受体的贡献尚不清楚。我们研究了 P2X1 受体在人血小板激活 FcγRIIa 中的作用,方法是通过交联抗 FcγRIIa 单克隆抗体 (mAb) IV.3 或用细菌刺激。在洗涤血小板悬浮液中通过测量细胞内 Ca([Ca])增加、ATP 释放和聚集来评估激活。通过预先添加 α,β-meATP、排除 apyrase 或拮抗剂 NF449 来消除 P2X1 活性。FcγRIIa 激活引起 [Ca]的强烈增加(在 30 μg/mL mAb 时为 441±33 nM),NF449、预先暴露于 α,β-meATP 或排除 apyrase 可将其减少到相似程度(至对照的 66-70%),表明 P2X1 受体有显著贡献。FcγRIIa 激活依赖性 P2X1 反应对一氧化氮 (NO)有一定抗性,但被 500 nM 前列环素 (PGI) 阻断。细菌和 FcγRIIa 激活的聚集反应也被 P2X1 受体脱敏抑制(分别为对照的 66%和 42%)。然而,FcγRIIa 介导的酪氨酸磷酸化和 ATP 释放并没有因 P2X1 活性的丧失而显著改变。总之,我们表明 P2X1 受体通过增加初始酪氨酸磷酸化事件和早期致密颗粒释放后的 [Ca]来增强血小板 FcγRIIa 受体引发的聚集。这代表了一种新途径,即 ATP 门控阳离子通道可以在体内促进血小板依赖性免疫反应。